These studies have underscored the significance of BA's inhibition of ATP-citrate lyase in macrophages and the liver, which may have implications in preventing the progression of non-alcoholic hepatic steatosis towards fibrosis and in modulating systemic inflammation [34, 35]. The gene discussed is ACLY; the disease is Hepatic steatosis.